Advertisement
(Logo: http://www.newscom.com/cgi-bin/prnh/20061005/ALLSCRIPTSLOGO-b)
The special cash dividend will be paid from the proceeds of the shareissuance contemplated by the Merger Agreement. The approval of such shareissuance is being sought at Allscripts' 2008 annual meeting of stockholders tobe held on October 6, 2008. The special cash dividend is in the aggregateamount of $330,000,000; the corresponding per share amount of the special cashdividend will not be determined until the actual number of shares ofAllscripts common stock outstanding as of the close of business on the recorddate of October 9, 2008 is determined. The payment of the special cashdividend will be made on October 17, 2008 on a pro-rata basis in respect ofall shares of Allscripts common stock outstanding as of the close of businesson the record date. Holders of Allscripts common stock who sell their sharesthrough the payment date also will be selling their right to receive thespecial cash dividend. The ex-dividend date for the special cash dividend isexpected to be October 20, 2008.
Advertisement
About Allscripts
Allscripts is the leading provider of clinical software, connectivity andinformation solutions that physicians use to improve healthcare. The company'sunique solutions inform, connect and transform healthcare, delivering improvedcare at lower cost. More than 40,000 physicians and thousands of otherhealthcare professionals in clinics, hospitals and extended care facilitiesnationwide utilize Allscripts to automate everyday tasks such as writingprescriptions, documenting patient care, managing billing and scheduling, andsafely discharging patients, as well as to connect with key information andstakeholders in the healthcare system. To learn more, visit Allscripts athttp://www.allscripts.com.
Additional Information and Where to Find It
This communication is being made in respect of the proposed businesscombination involving a subsidiary of Allscripts and Misys Healthcare Systems,LLC ("MHS"), a wholly owned subsidiary of Misys plc ("Misys"). In connectionwith this proposed transaction, Allscripts has filed with the Securities andExchange Commission (the "SEC") a definitive proxy statement. BEFORE MAKINGANY DECISION WITH RESPECT TO THE PROPOSED TRANSACTION, INVESTORS AND SECURITYHOLDERS ARE URGED TO READ THE PROXY STATEMENT AND OTHER RELEVANT MATERIALSWHEN THEY BECOME AVAILABLE, BECAUSE THEY WILL CONTAIN IMPORTANT INFORMATIONABOUT THE COMPANY AND THE PROPOSED TRANSACTION. Investors and security holderscan obtain copies of Allscripts' materials (and all other offer documentsfiled with the SEC) when available, at no charge on the SEC's website:http://www.sec.gov. Copies can also be obtained at no charge by directing arequest for such materials to Allscripts at 222 Merchandise Mart Plaza, Suite2024, Chicago, Illinois 60654, Attention: Lee Shapiro, Secretary. Investorsand security holders may also read and copy any reports, statements and otherinformation filed by Allscripts with the SEC, at the SEC public reference roomat 100 F Street, N.E., Washington, D.C. 20549. Please call the SEC at 1-800-SEC-0330 or visit the SEC's website for further information on its publicreference room. Allscripts' directors, executive officers and other members ofmanagement and employees may, under the rules of the SEC, be deemed to beparticipants in the solicitation of proxies from the stockholders ofAllscripts in favor of the proposed transaction. Information about Allscripts,its directors and its executive officers, and their ownership of Allscripts'securities, is set forth in its definitive proxy statement for the 2008 AnnualMeeting of Stockholders of the Company, which was filed with the SEC on August21, 2008.
Forward-Looking Statements
This communication contains forward-looking statements. Those forward-looking statements include all statements other than those made solely withrespect to historical fact. Forward-looking statements may be identified bywords such as "believes", "expects", "anticipates", "estimates", "projects","intends", "should", "seeks", "future", continue", or the negative of suchterms, or other comparable terminology. Such statements include, but are notlimited to, statements about the expected benefits of the transactioninvolving Allscripts, Misys Healthcare Systems, LLC and Misys, includingpotential synergies and cost savings, future financial and operating results,and the combined company's plans and objectives. In addition, statements madein this communication about anticipated financial results, future operationalimprovements and results or conditions and approvals are also forward-lookingstatements. Such forward-looking statements are subject to numerous risks,uncertainties, assumptions and other factors that are difficult to predict andthat could cause actual results to vary materially from those expressed in orindicated by them. Such factors may include, but are not limited to: (1) theoccurrence of any event, development, change or other circumstances that couldgive rise to the termination of the merger agreement; (2) the outcome of anylegal proceedings that have been or may be instituted against Allscripts,Misys or MHS and others following announcement of entering into the mergeragreement; (3) the inability to complete the proposed transaction due to thefailure to obtain stockholder or shareholder approval or the failure of anyparty to satisfy other conditions to completion of the proposed transaction;(4) risks that the proposed transaction disrupts current plans and operationsand potential difficulties in employee retention as a result of the merger;(5) the ability to recognize the benefits of the merger; (6) legislative,regulatory and economic developments; and (7) other factors described infilings with the Securities and Exchange Commission. Many of the factors thatwill determine the outcome of the subject matter of this communication arebeyond Allscripts', Misys' and MHS' ability to control or predict. Allscriptscan give no assurance that any of the transactions related to the merger willbe completed or that the conditions to the transactions will be satisfied.Allscripts undertakes no obligation to revise or update any forward-lookingstatement, or to make any other forward-looking statements, whether as aresult of new information, future events or otherwise. Allscripts is notresponsible for updating the information contained in this communicationbeyond the published date, or for changes made to this communication by wireservices or Internet service providers.
SOURCE Allscripts Healthcare Solutions, Inc.
